Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.06 USD | -0.13% | +4.37% | -24.35% |
Jun. 03 | Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate | MT |
Jun. 03 | Transcript : Intellia Therapeutics, Inc. - Special Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.35% | 2.23B | |
+56.67% | 59.34B | |
+43.17% | 40.24B | |
-4.97% | 39.88B | |
-5.56% | 28.55B | |
+14.75% | 27.26B | |
-21.57% | 19.23B | |
+31.73% | 12.61B | |
+2.49% | 12.49B | |
+25.78% | 12.28B |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- Transcript : Intellia Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 03